Literature DB >> 17000122

Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response.

Felix Yarovinsky1, Holger Kanzler, Sara Hieny, Robert L Coffman, Alan Sher.   

Abstract

Although Toll-like Receptors (TLRs) play a major function in innate recognition of pathogens, their role in antigen processing and presentation in vivo is poorly understood. Here we establish that Toxoplasma gondii profilin, a TLR11 ligand present in the parasite, is an immunodominant antigen in the CD4(+) T cell response to the pathogen. The immunogenicity of profilin was entirely dependent on both TLR11 recognition and signaling through the adaptor myeloid differentiation factor 88 (MyD88). Selective responsiveness to this parasite protein was regulated at the level of antigen presentation by dendritic cells (DC) and required both TLR signaling and major histocompatibility complex (MHC) class II recognition acting in cis. These findings support a major influence of TLR recognition in antigen presentation by DC in vivo and establish a mechanism by which TLR ligand association regulates the immunogenicity of microbial antigens.

Mesh:

Substances:

Year:  2006        PMID: 17000122     DOI: 10.1016/j.immuni.2006.07.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  45 in total

1.  CD8+ T cell immunodominance in lymphocytic choriomeningitis virus infection is modified in the presence of toll-like receptor agonists.

Authors:  Sarah Siddiqui; Sameh Basta
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.

Authors:  Harshita Satija Grover; Nicolas Blanchard; Federico Gonzalez; Shiao Chan; Ellen A Robey; Nilabh Shastri
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 3.  Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.

Authors:  Christina K Baumgartner; Laurent P Malherbe
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

4.  UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii.

Authors:  Reed Pifer; Alicia Benson; Carolyn R Sturge; Felix Yarovinsky
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

5.  Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors.

Authors:  Baidong Hou; Alicia Benson; Lili Kuzmich; Anthony L DeFranco; Felix Yarovinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

6.  TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity.

Authors:  Shirdi E Letran; Seung-Joo Lee; Shaikh M Atif; Satoshi Uematsu; Shizuo Akira; Stephen J McSorley
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

7.  TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.

Authors:  Dalia E Gaddis; Suzanne M Michalek; Jannet Katz
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

8.  Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens.

Authors:  Louise J Young; Nicholas S Wilson; Petra Schnorrer; Adele Mount; Rachel J Lundie; Nicole L La Gruta; Brendan S Crabb; Gabrielle T Belz; William R Heath; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

9.  CCR6-dependent recruitment of blood phagocytes is necessary for rapid CD4 T cell responses to local bacterial infection.

Authors:  Rajesh Ravindran; Lori Rusch; Andrea Itano; Marc K Jenkins; Stephen J McSorley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-05       Impact factor: 11.205

Review 10.  Understanding the multiple functions of Gr-1(+) cell subpopulations during microbial infection.

Authors:  Charlotte E Egan; Woraporn Sukhumavasi; Allison L Bierly; Eric Y Denkers
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.